Frenk Smrekar

Frenk Smrekar is a notable inventor based in Ljubljana, Slovenia. He has made significant contributions to the field of bacteriophage research, holding a total of 5 patents. His work focuses on developing therapeutic solutions for bacterial infections, showcasing his commitment to advancing medical science.

Latest Patents

Frenk's latest patents include innovative bacteriophage compositions. One of his notable inventions is a bacteriophage composition comprising one or more bacteriophages selected from Sa87, J-Sa36, or Sa83, or mutants thereof. This invention also encompasses the use of these compositions for medical or non-medical applications, including kits, bandages, and wound dressings. Another significant patent relates to therapeutic bacteriophage compositions specifically designed for treating bacterial infections. This disclosure involves a composition comprising obligately lytic bacteriophages capable of infecting and lysing bacteria, demonstrating his focus on addressing critical health challenges.

Career Highlights

Frenk Smrekar is currently associated with Armata Pharmaceuticals, Inc., where he continues to innovate in the field of bacteriophage therapy. His work at this company highlights his dedication to developing effective treatments for bacterial infections, which are increasingly becoming a global health concern.

Collaborations

Frenk collaborates with esteemed colleagues such as Gillian Mearns and Deborah A Rankin. Their combined expertise contributes to the advancement of research in bacteriophage therapy and its applications.

Conclusion

Frenk Smrekar's contributions to the field of therapeutic bacteriophage compositions are noteworthy. His innovative patents and ongoing work at Armata Pharmaceuticals, Inc. position him as a key figure in the fight against bacterial infections.